Great Dispersion in the Prognosis of Patients with Angina and No Coronary Lesions

The prognosis of patients with symptoms of angina (with all their subjectivity) in a setting of no significant coronary lesions is widely varied. It is not as benign as we initially thought and patients do not present as many events as “regular” patients with associated severe coronary lesions.

infarto peri-procedimientoThe literature owed us data on the long-term prognosis for these patients and that is precisely the subject matter of this work that was recently published in the European Heart Journal.

 

The authors searched for studies published on the subject up to 2017 that included the events all-cause death and nonfatal infarction. This meta-analysis included 54 studies with a total of 35,039 patients (mean age 56 years, male/female ratio: 0.51), all of them with typical angina symptoms and no significant coronary lesions.


Read also: The Crucial Significance of Lifestyle Changes.


After a 5-year follow-up (range: 3 to 7 years), the pooled global incidence of death and infarction was 0.98/100 person-years, with considerable heterogeneity among studies (p < 0.001).

 

The primary endpoint was associated with the presence of dyslipidemia (p = 0.016), diabetes (p = 0.035), and hypertension (p = 0.016). Studies enrolling patients with non-obstructive or non-significant coronary lesions, in angiographic terms, showed more events (1.32/100 person-years) than studies including only patients with entirely normal coronary arteries (0.52/100 person-years). However, there were no differences between studies enrolling patients with documented myocardial ischemia and studies that did not contemplate this pathology as a variable in the protocol.

 

In any case, ischemia documented by non-invasive imaging techniques was associated with a higher rate of events (p = 0.02).


Read also: Are Abdominal Aortic Aneurysm Screening Programs Overstated?


The Achilles’ heel for these patients is definitely the high rate of recurrent hospitalization due to angina, which often results in catheterization confirming the results of prior catheterizations: coronary arteries with no angiographically significant lesions.

 

Conclusion

The prognosis for patients with angina without significant lesions is heterogeneous. The main determinant of adverse events is the presence of “some” atherosclerosis and positive functional tests for ischemia in any area. The quality of life of these patients is affected by the high incidence of hospitalization, recurrent angina, and repeated catheterizations.

 

Original title: Determinants of Long-Term Clinical Outcomes in Patients with Angina but Without Obstructive Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Reference: Francesco Radico et al. Eur Heart J. 2018 Jun 14;39(23):2135-2146.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Esta es una entrada en ingles

demo en ingles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...